A new Chainalysis report reveals that gray-market peptide vendors are increasingly using stablecoins for transactions, with sales exceeding a $100 million annual run rate. This trend highlights stablecoins' growing utility as a payment rail for illicit or unregulated activities, driven by their speed and pseudonymous nature. For crypto, this underscores the dual-use nature of digital assets and the ongoing challenge of combating financial crime while maintaining privacy. Investors should monitor regulatory responses to stablecoin usage in gray markets, as increased scrutiny could impact their broader adoption and perceived legitimacy. The key data point is the $100M annual run rate for off-label peptide sales via crypto.
Stablecoins are proving to be a critical payment rail for gray markets, demonstrating real-world utility beyond speculative trading. This adoption reinforces stablecoins' role in the broader digital economy but also intensifies regulatory pressure on the crypto ecosystem to address illicit finance.
This story reveals the growing real-world utility of stablecoins as a payment mechanism, even in unregulated sectors. It signals that stablecoins are becoming indispensable, but their dual-use nature will inevitably invite stricter regulatory oversight, potentially impacting market liquidity and access.
Crypto has become a key payment rail for a fast-growing gray-market peptide trade, according to a new Chainalysis report. Chainalysis said Thursday that off-label peptide sales have climbed past a $100 million annual run rate, as online wellness trends and…